Cardiac resynchronization therapy in asymptomatic or mildly symptomatic heart failure patients in relation to etiology: results from the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) study
- PMID: 21087711
- DOI: 10.1016/j.jacc.2010.05.055
Cardiac resynchronization therapy in asymptomatic or mildly symptomatic heart failure patients in relation to etiology: results from the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) study
Abstract
Objectives: The purpose of this study was to determine the effects of cardiac resynchronization therapy (CRT) with respect to heart failure etiology among patients in the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) study.
Background: CRT improves outcomes in New York Heart Association functional class III/IV heart failure with wide QRS with a more pronounced effect on left ventricular (LV) reverse remodeling in nonischemic patients.
Methods: A total of 277 patients with nonischemic heart disease (IHD) and 333 with IHD etiology in New York Heart Association functional class I or II with QRS ≥120 ms and left ventricular ejection fraction ≤40% received a CRT (± implantable cardioverter-defibrillator) and were randomized to CRT-ON or CRT-OFF for 12 months. The primary end point was the percentage of patients worsened by the HF clinical composite response, and multiple prespecified secondary end points were evaluated regarding etiology using univariable and multivariable analysis.
Results: At baseline, IHD patients were significantly older and had more comorbidities and less dyssynchrony than non-IHD patients. In non-IHD patients, 10% worsened in CRT-ON compared with 19% in CRT-OFF (p = 0.01). In IHD patients, 20% worsened in the CRT-ON compared with 24% in the CRT-OFF group (p = 0.10). Non-IHD patients assigned to CRT-ON improved more in left ventricular end-systolic volume index than IHD patients. Randomization to CRT, left bundle branch block, and wider QRS duration independently predicted response to both end points, whereas non-IHD etiology was an independent predictor only for left ventricular end-systolic volume index.
Conclusions: This substudy of REVERSE shows that CRT reverses left ventricular remodeling with a more extensive effect on nonischemic patients. Etiology was, however, not an independent predictor of clinical response. (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction [REVERSE]; NCT00271154).
Copyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.J Am Coll Cardiol. 2009 Nov 10;54(20):1837-46. doi: 10.1016/j.jacc.2009.08.011. Epub 2009 Oct 1. J Am Coll Cardiol. 2009. PMID: 19800193 Clinical Trial.
-
Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).Eur Heart J. 2011 Jul;32(13):1631-9. doi: 10.1093/eurheartj/ehq408. Epub 2010 Nov 25. Eur Heart J. 2011. PMID: 21112898 Clinical Trial.
-
Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.Am Heart J. 2006 Feb;151(2):288-94. doi: 10.1016/j.ahj.2005.03.002. Am Heart J. 2006. PMID: 16442890
-
Cardiac resynchronization therapy for prevention of heart failure events in elderly patients with left ventricular dysfunction.Expert Rev Cardiovasc Ther. 2012 Oct;10(10):1319-27. doi: 10.1586/erc.12.120. Expert Rev Cardiovasc Ther. 2012. PMID: 23190070 Review.
-
Cardiac resynchronization therapy: what? Who? When? How?Am J Med. 2011 Sep;124(9):813-5. doi: 10.1016/j.amjmed.2010.09.028. Am J Med. 2011. PMID: 21854888 Review.
Cited by
-
Electrical devices for left ventricular dysfunction and heart failure: do we need revised guidelines?J Interv Card Electrophysiol. 2012 Aug;34(2):197-204. doi: 10.1007/s10840-011-9639-0. Epub 2011 Dec 17. J Interv Card Electrophysiol. 2012. PMID: 22173864
-
Impact of etiology on the outcomes in heart failure patients treated with cardiac resynchronization therapy: a meta-analysis.PLoS One. 2014 Apr 14;9(4):e94614. doi: 10.1371/journal.pone.0094614. eCollection 2014. PLoS One. 2014. PMID: 24732141 Free PMC article.
-
Efficacy and safety of dapagliflozin according to aetiology in heart failure with reduced ejection fraction: insights from the DAPA-HF trial.Eur J Heart Fail. 2021 Apr;23(4):601-613. doi: 10.1002/ejhf.2124. Epub 2021 Mar 10. Eur J Heart Fail. 2021. PMID: 33594755 Free PMC article. Clinical Trial.
-
Volumetric Response beyond Six Months of Cardiac Resynchronization Therapy and Clinical Outcome.PLoS One. 2015 May 1;10(5):e0124323. doi: 10.1371/journal.pone.0124323. eCollection 2015. PLoS One. 2015. PMID: 25933068 Free PMC article.
-
Clinical, laboratory, and pacing predictors of CRT response.J Cardiovasc Transl Res. 2012 Apr;5(2):196-212. doi: 10.1007/s12265-012-9352-0. Epub 2012 Feb 24. J Cardiovasc Transl Res. 2012. PMID: 22362181 Review.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous